Pharmacy Compliance- Credentialing, HIPAA and Fraud, Waste and Abuse (FWA) ACPE# L04-P ACPE# L04-T

Similar documents
Compliance and Fraud, Waste, and Abuse Awareness Training. First Tier, Downstream, and Related Entities

IEHP Medicare DualChoice Program Pharmacy Program Manual

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training

Developed by the Centers for Medicare & Medicaid Services Issued: February, 2013

Developed by the Centers for Medicare & Medicaid Services

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training. Developed by the Centers for Medicare & Medicaid Services

Commitment to Compliance

Compliance Program. Health First Health Plans Medicare Parts C & D Training

FWA (Fraud, Waste and Abuse) Training

Medicare Part D: Retiree Drug Subsidy

COMPLIANCE TRAINING 2015 C O M P L I A N C E P R O G R A M - F W A - H I P A A - C O D E O F C O N D U C T

Health Alliance Plan utilizes the Centers for Medicare and Medicaid Services (CMS) current definitions to define (FDRs):

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All MASSACHUSETTS WORKFORCE MEMBERS

Medicare Parts C & D Fraud, Waste, and Abuse Training

DEFICIT REDUCTION ACT AND FALSE CLAIMS POLICY INFORMATION FOR All NEW YORK WORKFORCE MEMBERS

Mission Statement. Compliance & Fraud, Waste and Abuse Training for Network Providers 1/31/2019

This course is designed to provide Part B providers with an overview of the Medicare Fraud and Abuse program including:

Compliance Fraud, Waste and Abuse HIPAA Privacy and Security

STRIDE sm (HMO) MEDICARE ADVANTAGE Fraud, Waste and Abuse

D E B R A S C H U C H E R T, C O M P L I A N C E O F F I C E R

FDR. Compliance Guide

Fraud, Waste and Abuse: Compliance Program. Section 4: National Provider Network Handbook

Medicare Parts C & D Fraud, Waste, and Abuse Training and General Compliance Training

Required CMS Contract Clauses Revised 8/28/14 CMS MCM Guidance Chapter 21

ANTI-FRAUD PLAN INTRODUCTION

MMP (CalMediconnect) Community Health Group. and. First Tier, Downstream & Related Entity

COMPLIANCE; It s Not an Option

**** CMS Regulation-Action Required****

Scope: Hometown Health Compliance Policies & Procedures apply to the following individuals and entities:

Fraud, Waste and Abuse A Presentation for Network Providers

Fraud, Waste and Abuse

Corporate Legal Policy

Amy Bingham, Compliance Director Reviewed Only Date: 6/05,1/31/2011, 1/24/2012 Supersedes and replaces: "CC-02 - Anti-

First Tier Entity Attestation 2017 Medicare Advantage Organization (Sponsor) Compliance Program

Ridgecrest Regional Hospital Compliance Manual

Special Advisory Bulletin

Medicare Parts C & D General Compliance Training

CORPORATE COMPLIANCE POLICY AND PROCEDURE

Medical Monitoring Program: PPACA and CMS Final Recommended Guidelines vs. Rules: New License Monthly Screening Requirements

MEDICARE PRESCRIPTION DRUG PART D COMPLIANCE CONFERENCE. Reporting Requirements: Audit Preparedness for PDPs and Manufacturers

Standards of Conduct Compliance & Training Requirements for Providers - First Tier, Downstream & Related Entities (FDR)

2016 Business Associate Workforce Member HIPAA Training Handbook

FDR Compliance Guide. Paramount

Health Care Fraud for Physicians

Code of Conduct/Ethics Policies and Procedures

CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND TEXAS GENERAL SURGEONS

9/26/2012. Medical Identity Theft. Definition. Types of Medical Identity Theft

FRAUD, WASTE, & ABUSE (FWA) for Brokers. revised 10/17

HIPAA Privacy & Security. Transportation Providers 2017

ATTACHMENT B PHARMACY CREDENTIALING FORM

STANDARDS OF CONDUCT For Care1st s Contracted First-Tier, Downstream, and Related Entities (FDRs)

MNsure Certified Application Counselor Services Agreement with Tribal Nation Attachment A State of Minnesota

Vendor Code of Business Conduct & Ethics

Certifying Employee Training Navicent Health s Corporate Integrity Agreement Year Two

MENTAL HEALTH MENTAL RETARDATION OF TARRANT COUNTY. Board Policy. Number A.3 July 31, 2001 COMPLIANCE PLAN

CODE OF BUSINESS CONDUCT COMPLIANCE AND ETHICS PROGRAM Knowledge Check Questions

Improving Integrity in Nursing Centers

1 Security 101 for Covered Entities

In this course, we will cover the following topics: The structure and purpose of Navicent Health s Compliance Program The requirements of the

C. Enrollees: A Medicaid beneficiary who is currently enrolled in the MCCMH PIHP.

Answers to Frequently Asked Questions

CMS Part D UPDATES. Kim Brandt Director, Program Integrity Centers for Medicare & Medicaid Services

Region 10 PIHP FY Corporate Compliance Program Plan

Charging, Coding and Billing Compliance

HOSPITAL COMPLIANCE POTENTIAL IMPLICATION OF FRAUD AND ABUSE LAWS AND REGULATIONS FOR HOSPITALS

From the auditor s desk. Updating pharmacy demographics with NCPDP. Responding to daily pre-payment review requests

PREVENTION, DETECTION, AND CORRECTION OF FRAUD, WASTE AND ABUSE

From the auditor s desk. Billing compounds as single-ingredient claims. Submit Compound Prescription with a code of 2 in the Compound Code field.

Disclaimer LEGAL ISSUES IN PHYSICAL THERAPY

HIPAA Training. HOPE Health Facility Administrators June 2013 Isaac Willett and Jason Schnabel

Prime Perspective. From the auditor s desk. Quarterly Pharmacy Newsletter from Prime Therapeutics LLC INSIDE. September 2018: Issue 73

OHC CORPORATE COMPLIANCE PROGRAM (ACF & ECF) DOING THE RIGHT THING

HIPAA COMPLIANCE ROADMAP AND CHECKLIST FOR BUSINESS ASSOCIATES

CCP Anti-Fraud Plan MMA

Corporate Compliance Program. Intended Audience: All SEH Associates 2016 Content Expert: Lisa Frey -

2012 Checklist for Community Pharmacy. Medicare Part D-Related Information

Customized Delivery Solutions Mail Order

Medicare Parts C and D General Compliance Training

A Day In The Life Of A Healthcare Fraud Investigator

Fraud and Abuse in the Medicare Program

Community Care Plan (CCP) Anti-Fraud Plan MMA

Sharp HealthCare s 2017 Compliance Education. Fraud, Waste, and Abuse: Prevention, Detection and Reporting Module 2

Prescription Drug Benefit Manual

National Policy Library Document

Qualified Medicare Beneficiary Program

ALABAMA MEDICAID AGENCY ADMINISTRATIVE CODE CHAPTER 560-X-4 PROGRAM INTEGRITY DIVISION TABLE OF CONTENTS

Contracting with Specialty Pharmacies and Hubs 17 th Annual Pharma and Medical Device Compliance Congress. October 20, 2016

DPW's Mandate to Perform Monthly Sanction Screenings: Implications and Strategies for County Government MH/DS and SCAs

The Intersection of Specialty Pharmacy and the Law

March 1. HIPAA Privacy Policy

ANCILLARY services: How to Stay Out of Trouble. The neurosurgical minefield Informed consent

MEDICARE COMPLIANCE PROGRAM GUIDE F I R S T T I E R, D O W N S T R E A M, A N D R E L A T E D E N T I T I E S ( F D R )

HTKT.book Page 1 Monday, July 13, :59 PM HIPAA Tool Kit 2017

Regulatory Compliance Policy No. COMP-RCC 4.21 Title:

STANDARDS OF CONDUCT

Prime Perspective. From the auditor s desk. Quarterly Pharmacy Newsletter from Prime Therapeutics LLC. INSIDE From the auditor s desk...

Sharmin Rahman, BS Consultant, Compliance. Senior Manager, Compliance. Objectives. We the People - Government Authority

Medical Ethics. Paul W. Kim, JD, MPH O B E R K A L E R

Telemedicine Fraud and Abuse Under the Microscope

OMNIBUS COMPLIANT BUSINESS ASSOCIATE AGREEMENT RECITALS

Transcription:

Pharmacy Compliance- Credentialing, HIPAA and Fraud, Waste and Abuse (FWA) ACPE# 0761-9999-16-075-L04-P ACPE# 0761-9999-16-075-L04-T

Credentialing and Other Terms the Pharmacy Should Know

What are all these terms and acronyms? Credentialing - the process of establishing the qualifications of licensed professionals, facilities or organizations, and assessing their background and legitimacy. HIPAA- Health Insurance Portability and Accountability Act (law protecting personal health information) FWA - Fraud, Waste and Abuse Compliance - conformity in fulfilling official requirements

OIG/GSA Reviews FWA Training Compliance / Code of Conduct Training HIPAA Training Records Retention CMS 10147 Compliance Requirements Pseudoephedrine Training Drug Supply Chain Security Quality Assurance Program/ Error Reporting Current Licensure: State, Pharmacist (PIC), DEA, Certificate of Insurance, etc.

Effective Compliance Program

Health Insurance Portability and Accountability Act (HIPAA)

Privacy Rule (164.5xx) Went into effect in April of 2003. Addresses how you may use and disclose Protected Health Information (PHI) Provides the patient with specific rights when it comes to their PHI Requires the designation of a Privacy Official (Officer)

Individual s Rights Notice of Privacy Practices Access to Records Amendment of Records Accounting of Disclosures Confidential Communications Additional Restrictions

Patients Rights Patient has the right to amend their records if they believe their records are incorrect or incomplete. Patient can request that you communicate with them in alternate means or locations. Patient can request additional restrictions be made to the uses and disclosures of their PHI. Omnibus specified that a patient could request that you do not release PHI to payers for services paid out-ofpocket

Definitions Uses means, with respect to individually Identifiable health information, the sharing, employment, application, utilization, examination, or analysis of such information within the Pharmacy Disclosures means the release, transfer, provision of access to, or divulging in any manner of information outside the entity holding the information.

Uses and Disclosures For Treatment, Payment and Health Care Operations That Require Authorizations Requiring an Opportunity for the Patient to Agree or Object Not Requiring an Opportunity for the Patient to Agree or Object

Minimum Necessary All uses and disclosures must be comprised of the minimum amount of Protected Health Information necessary to meet the purpose of the use or disclosures.

Valid Authorizations A Valid Authorization must have: Description of the PHI that will be used or disclosed Persons or entities that will be receiving the PHI Purpose of the use or disclosure Expiration date of the authorization Patient Signature and date signed Wording that the patient may revoke the authorization

Identity Verification The Pharmacy must verify the identity of a person/entity requesting PHI and the authority of any such person to have access to PHI.

HIPAA Housekeeping Policies and Procedures Must have policies and procedures to comply with the regulations Employee Sanctions Must have a process to apply sanctions to an employee who violates your HIPAA Practices Record Retention Must maintain records for at least 6 years Training Must train your employees on your policies and procedures If you purchased a training program that is not based on your policies and procedures then you are non-compliant.

HIPAA Housekeeping (cont.) Employee Access You must evaluate and document each employee based on the level of access to PHI they need in order successfully perform their job function. Inventory of PHI You need to identify all of the locations (Physical and Electronic) in your Pharmacy that contain PHI. Cannot protected what you do not know exists. Complaints A process to address complaints concerning HIPAA compliance

Business Associates A business associate is a person or entity that performs certain functions or activities that involve the use or disclosure of PHI on behalf of, or provides services to, a covered entity.

Examples of Business Associates Accounting Services Legal Services Computer Software Vendors Consulting Services Online Storage entities E-Prescribing Services Shredding Companies Medical Billers? Yes No Are they a Business Associate? They come in contact with or potentially come in contact with personal health information Their services do not cause them to have access to personal health information.

Breach Notification Rule (164.4xx) Must report a breach unless there is a low probability that the protected health information has been compromised based on a risk assessment Notify the affected individual(s)within 60 days of discovery 500 or more persons affected, notify HHS with 60 days of discovery Less than 500 persons affected, notify HHS within 60 days of the end of the year

Security Rule (164.3xx) Went into effect in April of 2005 Governs how to ensure the confidentiality, integrity and availability of Electronic PHI Requires the designation of a Security Official (Officer) with an understanding of your Computers and Network

Physical Safeguards Facility Access Controls Workstation Use Workstation Security Device and Media Controls

Technical Safeguards Access Controls Audit Controls Integrity Person or Entity Authentication Transmission Security

Administrative Safeguards Security Management Process Workforce Security Information Access Management Security Awareness and Training Security Incident Procedure Contingency Plan Evaluation

Fraud, Waste, and Abuse (FWA)

Background The overall purpose of the fraud, waste, and abuse requirement is to protect the federal government and Medicare Part D beneficiaries from fraudulent, wasteful and abusive schemes, risks and vulnerabilities through the prescription drug benefit. 25

Definitions Fraud is defined as making false statements or representations of material facts in order to obtain some benefit or payment for which no entitlement would otherwise exist. Waste is typically described as the over-utilization or misuse of services. The act of waste is typically not criminal or intentional. Abuse describes practices that, either directly or indirectly, result in unnecessary costs to the Medicare program. 26

Regulations All Sponsors are required to have a comprehensive plan to detect, correct and prevent fraud, waste and abuse according to the Medicare Modernization Act. While it may be common practice for Sponsors to enter into contracts with third parties to perform certain functions that would otherwise be the responsibility of the Sponsor, the Sponsor maintains ultimate responsibility for fulfilling the terms and conditions as set out in the contract with CMS. Whenever a Sponsor delegates any of its activities or responsibilities to any related entity, contractor, subcontractor or pharmacy, the written arrangements must either provide for revocation of the delegation activities or specify other remedies in instances when CMS or the Sponsor determine that the parties have not performed satisfactorily. 27

Plan Sponsor and PBM Areas of Focus Daily Audit Programs Hospice, ESRD, COB Excluded Provider Exclusions Onsite Audits Corrective Action Programs Credentialing / Re-credentialing program FWA report creation/ review HEAT area reporting / investigative monitoring Investigation including Invoice Auditing Medicare Drug Integrity Contractors (MEDIC) information sharing Law Enforcement / MEDIC referrals

Medicare Prescription Drug Benefit Manual Chapter 9, The Part D Program to Control Fraud, Waste, and Abuse: Potential Fraud, Waste and Abuse schemes can be perpetrated by prescribers, members, and pharmacies: 29

Common attributes of fraudulent schemes: - A significant increase in prescription orders and claim submissions from one physician and/or office Prescriber s will be difficult to contact and/or only the front office nurse or office manager will answer the phone or return calls upon verification attempts The prescriber listed on the Rx may be new to the area and unfamiliar to the pharmacy Physician Assistant s writing for Rx s without proper identification on prescriptions Repetitive patterns may contain the same drug or drug class, strengths and dosing for each member and will be for single source brand name drugs only In many cases, such prescriptions will be written for a 90-day supply Member specifically requests sealed medication bottles - Members traveling great distances to obtain their prescriptions at the pharmacy - Frequent misspelled addresses, cities, names, and/or drugs - Perfectly written or incorrect prescriptions with same script from different prescribers 30

Examples of Fraud, Waste and Abuse by prescribers to watch for: Illegal remuneration schemes prescriber is offered, paid, solicits or receives unlawful remuneration to induce or reward the prescriber to write prescriptions (kick backs) Prescription drug switching offers in cash or other benefit to prescribe one drug over another Script mills writing prescriptions for drugs that are not medically necessary, often in mass quantities, and often for individuals that are not his or her patients Theft of prescriber s Drug Enforcement Administration (DEA) number, Prescription pad, or e-prescribing authentication information and log-in 31

Examples of Fraud, Waste and Abuse by members to watch for: Over-utilization and drug seeking drug abuse (not limited to narcotics) Altered and forged prescriptions dates, strengths, quantities, refills, false claims Members initiating their own phone-in prescriptions Pharmacy hopping and doctor shopping review history of member Drug diversion and inappropriate use obtains drugs used by another non-covered party, or for resale on the black market Misrepresentation of status member misrepresents identity, eligibility, medical conditions to obtain benefits 32

Examples of Fraud, Waste and Abuse by pharmacies to watch for: Billing for brand and dispensing generic drugs Over-billing of quantity prescribed and inappropriate billing of compounds Over-billing of quantity in relation to days supply /reducing qty to avoid p/a False or fictitious claims submission Document fabrications and alterations Forged signature logs or insufficient proof of delivery Not processing returns to stock/not crediting for destroyed returns Use of dummy DEA s/national Provider Identifier (NPI) Inappropriate use of Dispense As Written (DAW) codes Billing of unauthorized refills Billing under expired prescriptions Prescription splitting to obtain multiple dispensing fees Pill shorting billing for more than dispensed Recycling medications black market repurchases for resale Failure to offer negotiated prices 33

Elements of FWA programs 1. Written Policies and Procedures required by pharmacies 2. Exclusion Lists 3. Staff Training and Education 4. Conflict of Interest 34

Written Policies and Procedures Written policies, procedures, and standards of conduct clearly stating a Sponsor or Pharmacy s commitment to comply with all applicable Federal and state statutory, regulatory and other requirements related to the Medicare program are a critical component of a comprehensive program to detect, prevent and control fraud, waste and abuse. The Code of Conduct and the applicable policies and procedures should be made available to employees at time of hire, when the standards are updated, and annually thereafter. As a condition of employment, employees should certify that they have received, read, and will comply with all written standards of conduct. Written policies, procedures and standards of conduct should be updated as necessary to incorporate any changes in applicable laws, regulations, and other requirements. 35

Exclusion Lists Pharmacies contracted with Medicare D plan sponsors or their PBMs are required to comply with CMS requirements. Screening of Employees Employees should be checked against the OIG and GSA lists at time of hire and monthly thereafter to ensure that no employee is prohibited from participation in the Medicare program. 36

OIG - http://exclusions.oig.hhs.gov/ The Online Searchable Database enables users to enter the name of an individual or entity and determine whether they are currently excluded. If a name match is made, the database can verify the match using a Social Security Number or Employer Identification Number. 37

GSA www.sam.gov All entity records from CCR/FedReg and ORCA and exclusion records from EPLS, active or expired, were moved to SAM. You can search these records and new ones created in SAM. 38

Conflict of Interest Conflicts of interest are created when an activity or relationship renders a person unable or potentially unable to provide impartial assistance or advice, the person s objectivity is impaired, or a person has an unfair competitive advantage. 39

Important Points to Remember The pharmacy has a legal and contractual duty to not submit false claims, including claims arising from the previous noted schemes; If the pharmacy has a significant increase in a particular prescriber s prescriptions, pharmacy should directly contact such prescriber to determine legitimacy of such prescriptions; and Verify authenticity of members form of identification receiving prescriptions by asking the Member to confirm information on the identification they have provided Be cognizant of schemes involving patient recruiting schemes where identities are stolen Know your patient and their medical condition Be careful about engaging in the practice of pre-signed delivery authorizations Question medical practices channeling new business to your pharmacy If it sounds too good to be true or doesn t seem right, it probably isn t. Question it! 40

Reporting FWA How can you report actual or suspected Fraud, Waste or Abuse? In most cases, an immediate supervisor may be in the best position to address issues. PBMs and Medicare Sponsor processors have a Hotline or reporting protocol. Reports of FWA or compliance are to be treated as Confidential Employees are protected from retaliation under the False Claims Act for False Claims Act complaints. 41

Where Should I Report Fraud and Abuse? I am a Report to Medicare Beneficiary For any complaints: CMS Hotline: 1-800-MEDICARE (1-800-633-4227) ortty 1-800-486-2048 OR For Medicare Managed Care or Prescription Drugs:1-877-7SafeRx (1-877-772-3379) Medicare Provider Medicaid Beneficiary or Provider OIG Hotline Phone: 1-800-HHS-TIPS (1-800-447-8477) Fax: 1-800-223-8164 E-mail: HHSTips@oig.hhs.gov TTY: 1-800-377-4950 https://oig.hhs.gov/fraud/hotline/report-fraud-form.aspx Mail: US Department of Health and Human Services Office of Inspector General Attn: OIG Hotline Operations P.O. Box 23489 Washington, DC 20026 OR your local Medicare Carrier, FI, or MAC OIG Hotline Phone: 1-800-HHS-TIPS (1-800-447-8477) Fax: 1-800-223-8164 E-mail: HHSTips@oig.hhs.gov TTY: 1-800-377-4950 https://oig.hhs.gov/fraud/hotline/report-fraud-form.aspx Mail: US Department of Health and Human Services Office of Inspector General Attn: OIG Hotline Operations P.O. Box 23489 Washington, DC 20026 OR your Medicaid State Agency (State Agency Fraud Units are listed at http://www.cms.gov/medicare-medicaid-coordination/fraud- Prevention/FraudAbuseforConsumers) 42

Penalties of Violating FWA Network Termination Payment Suspension Suspension of Enrollment and Marketing Activity Plan Sponsors Civil Monetary Penalties Under 42 U.S.C. Section 1320a-7a, CMPs may be imposed for a variety of conduct, and different amounts of penalties and assessments may be authorized based on the type of violation at issue. Penalties range from up to $10,000 to $50,000 per violation. CMPs can also include an assessment of up to 3 times the amount claimed for each item or service, or up to 3 times the amount of remuneration offered, paid, solicited, or received. Examples of CMP violations include: Presenting a claim that the person knows or should know is for an item or service that was not provided as claimed or is false and fraudulent, Presenting a claim that the person knows or should know is for an item or service for which payment may not be made, and Violating the Anti-Kickback Statute. 43